Drug Industry
Concept
Vocabulary Service
Overview
subject area of
-
A Prospective Before-and-After Trial of an Educational Intervention about Pharmaceutical Marketing Academic Article
-
Academic medicine and the pharmaceutical industry: a cautionary tale. Academic Article
-
Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding Academic Article
-
Agreements between industry and academia on publication rights: A retrospective study of protocols and publications of randomized clinical trials Academic Article
-
Antileukotrienes, asthma pathogenesis and the pharmaceutical industry. Academic Article
-
Assessing the quality of drug detailing Academic Article
-
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Academic Article
-
Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis Academic Article
-
Awareness and attitudes of the Lebanese population with regard to physician–pharmaceutical company interaction: a survey study Academic Article
-
BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles Academic Article
-
Balancing quality and cost: a public decision-making process. Academic Article
-
Bill C-91: the debate continues. Academic Article
-
Canada’s New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem Academic Article
-
Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform: Figure 1: Academic Article
-
Clinical experts or methodologists to write clinical guidelines? Academic Article
-
Combination Therapy to Prevent Cardiovascular Disease Academic Article
-
DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS Academic Article
-
DTCA in New Zealand: the challenge of finding an acceptable balance. Academic Article
-
Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training. Academic Article
-
Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods Academic Article
-
Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor Academic Article
-
Development of a standardized, comprehensive "ideal drug detail". Academic Article
-
Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont. Academic Article
-
Direct to consumer advertising Academic Article
-
Disappearing Acts: Anguish, Isolation, and the Re-imagining of the Mentally Ill in Global Psychopharmaceutical Advertising (1953–2005) Academic Article
-
Do editors live up to the Sept 10, 2001, expectations? Academic Article
-
Doctors must be trained to assess credibility Academic Article
-
Drug Development: From Concept to Marketing! Academic Article
-
Effect of Pressure on Molecular and Ionic Motions in Ultraviscous Acetaminophen–Aspirin Mixture Academic Article
-
Extent of physician–pharmaceutical industry interactions in low-and middle-income countries: a systematic review Academic Article
-
Factors associated with drug shortages in Canada: a retrospective cohort study Academic Article
-
Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials Academic Article
-
Financial relationships between patient and consumer representatives and the health industry: A systematic review Academic Article
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery Academic Article
-
GRADE guidelines: 5. Rating the quality of evidence—publication bias Academic Article
-
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada Academic Article
-
Health sciences and the pharmaceutical industry: partnerships can be effective and ethical. Academic Article
-
How should we support pharmaceutical innovation? Academic Article
-
Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials Academic Article
-
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model Academic Article
-
Industry funded patient information and the slippery slope to New Zealand Academic Article
-
Integrating medication samples into the traditional community pharmacy supply chain: a feasibility study Academic Article
-
Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. - PubMed - NCBI Article
-
Investigator-initiated trials are more impartial Academic Article
-
Is the GAIN Act a turning point in new antibiotic discovery? Academic Article
-
Knowledge, beliefs and attitudes of patients and the general public towards the interactions of physicians with the pharmaceutical and the device industry: a systematic review Academic Article
-
Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review Academic Article
-
LETTERS TO THE EDITOR Academic Article
-
Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review Academic Article
-
Managing drug shortages during a pandemic: tocilizumab and COVID-19 Academic Article
-
Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. Academic Article
-
New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit? Academic Article
-
New approaches to rewarding pharmaceutical innovation Academic Article
-
New drug development Academic Article
-
No free lunch. Academic Article
-
Novel approaches to discovery of antibacterial agents Academic Article
-
Optimal Global Value of Information Trials: Better Aligning Manufacturer and Decision Maker Interests and Enabling Feasible Risk Sharing Academic Article
-
Optimal sample size determinations from an industry perspective based on the expected value of information Academic Article
-
Oral anticoagulant therapy. Urgent need for standardization. Academic Article
-
Pediatric drug data in Canadian drug monographs: a descriptive analysis Academic Article
-
Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows. Academic Article
-
Response to Maubach and Hoek's paper on GP attitudes to DTCA. Academic Article
-
Revitalizing Pharmaceutical Innovation For Global Health Academic Article
-
SSRI treatment for under-18s Academic Article
-
Sir William Osler (1849-1919): His Opinion of Modern Therapeutics Academic Article
-
Something old, something new: revisiting natural products in antibiotic drug discovery Academic Article
-
Stakeholder Involvement: How to Do It Right Academic Article
-
Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines Academic Article
-
Stopping a trial early in oncology: for patients or for industry? Academic Article
-
The Impact of Drug Vintage on Patient Survival: A Patient-Level Analysis Using Quebec's Provincial Health Plan Data Academic Article
-
The Impact of Tiered-Pricing Framework on Generic Entry in Canada Academic Article
-
The NICE Reference Case Requirement Academic Article
-
The Opportunity Cost of Capital Academic Article
-
The Process Analytical Technology initiative and multivariate process analysis, monitoring and control Academic Article
-
The Self-Perceived Role and Educational Needs of Pharmaceutical Representatives: A Survey Academic Article
-
The art and science of marketing medications. Academic Article
-
The cost of drug development: A systematic review Academic Article
-
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'. Academic Article
-
The shipwreck of the singular Academic Article
-
Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance Academic Article
-
Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately? Academic Article
-
Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review Academic Article
-
Value of Information and Pricing New Healthcare Interventions Academic Article
-
Value-based arrangements may be more prevalent than assumed Academic Article
-
What do Canadians think about physician–pharmaceutical industry interactions? Academic Article
-
When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing Academic Article
-
Why West Africa rejected donation of Chinese medicine for treating Ebola recommended by Chinese government? Academic Article
-
“A magical little pill that will relieve you of your womanly issues”: What young women say about menstrual suppression Academic Article